Years after initial tests, researchers are now racing to see if a vaccine developed in 2011 can help fight the current Bundibugyo outbreak in Congo.
A London clinic owner has claimed he is treating people with stage 4 cancer by sealing them into a plastic bag while they’re naked from the waist down and gassing them with chlorine dioxide.
Wellness influencers have stumbled onto a huge issue when it comes male fertility, though not every solution they’re pitching is good advice.
Customers have complained that a telehealth network selling compounded GLP-1s has been ripping them off—even after it had to pay $5 million to clients as part of a settlement with the US government.
The USDA this week confirmed the first known infection of the carnivorous fly larva, which feast on the flesh of living mammals, after the United States eradicated the nightmare bugs in the 1960s.
Sellers of products with names like Boner Bears and DTF have voluntarily recalled their products after testing positive for the active ingredients in Viagra and Cialis.
There might finally be a way forward for long Covid treatment—if only you were allowed to talk about it.
From specialized motors to the use of machine learning algorithms, Turkey’s billion-dollar hair-transplant industry is the result of a constant process of innovation.
The Centers for Research in Emerging Infectious Diseases were launched during the Covid-19 pandemic. The group lost its funding under Trump in part due to conspiracy theories.
CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV.